K. Blyth (Glasgow, United Kingdom), J. Janssen (Nijmegen, Netherlands), K. Lamote (Wilrijk, Belgium), S. Zarogiannis (Larisa, Greece)
TGF-ß participates in epithelial-mesenchymal transition in pleural fibrosis via targeting S100A4 Z. Sun (China)
| |
Gender differences in asbestos exposure and disease location in 327 patients with mesothelioma J. Bak (Randers, Denmark)
| |
The axis of ?MGB1 and soluble RAGE levels in pleural effusions from various etiologies. O. Kotsiou (Larisa, Greece)
| |
Evaluation of New Biomarkers in Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure M. Demir (DIYARBAKIR, Turkey)
| |
Can suspicion for malignancy improve the indication of video-assisted thoracoscopic surgery (VATS) in patients with pleural effusion of unknown cause? T. Aiello (Barcelona, Spain)
| |
Imaging in Pleural Infections: The Radiation Adds Up C. Wilshire (Seattle, United States of America)
| |
Equalisation of negative intra-pleural pressure via Tunnelled Pleural Catheters (TPCs): a novel practice. A. Ewence (Salisbury, United Kingdom)
| |
The role of Epithelial sodium channel (ENaC) in cell proliferation and tunneling nanotube (TnT) formation in benign mesothelial cells and malignant pleural mesothelioma (MPM) cells. O. Kotsiou (Larisa, Greece)
| |
Tunnelled indwelling pleural catheters and trapped lung in malignant mesothelioma Y. Madani (London, United Kingdom)
| |
Inflammatory appearance of the parietal pleura at thoracoscopy – what does it hide? Y. Madani (London, United Kingdom)
| |
Alternative way of tunneling a pleural catheter using a single puncture - our experiences, safety and effectivity. D. Havel (Plzen 1, Czech Republic)
| |
Current etiological profile of clear liquid exudative pleural effusion H. Smadhi (ARIANA, Tunisia)
| |
Thymic neoplasms: clinical presentation, diagnosis and management - A single institution experience D. Mursic (Zagreb, Croatia)
| |
SOLITARY FIBROUS TUMOR OF THE PLEURA: OUR EXPERIENCE I. Jimenez Setuain (Burlada (Navarra), Spain)
| |
Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? M. Perez Warnisher (Madrid, Spain)
| |
Pleural fluid ‘cell block’ analysis in malignant pleural effusion: sensitive, superior over fluid cytology and suitable for immunohistochemistry analysis (IHC), will decrease need for thoracoscopy guided procedures P. Shital (Latur (Maharashtra), India)
| |
Malignant pleural mesothelioma:a 16-year, single centre experience M. Brandão (Vila Nova de Gaia, Portugal)
| |
Refining the breath fingerprint of mesothelioma patients by in vitro identification of cancer cell line-specific volatile metabolites S. Lagniau (Gent, Belgium)
| |
The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients. P. Petborom (Nakhon Nayok, Thailand)
| |
Role of rapid on-site evaluation (ROSE)-cytology of pleural crush biopsy samples in diagnostic pleuroscopy (medical thoracoscopy) for assessing requirement of pleurodesis in the same sitting in a TB endemic country K. Gera (FARIDABAD (HARYANA), India)
| |